• DOI:10.1021/JS980173A
Corpus ID: 35081505

Pharmacokinetic considerations in obesity.

@article{Blouin1999PharmacokineticCI,
  title={Pharmacokinetic considerations in obesity.},
  author={R. Blouin and G. W. Warren},
  journal={Journal of pharmaceutical sciences},
  year={1999},
  volume={88 1},
  pages={
          1-7
        }
}

R. Blouin, G. W. Warren

Published 1999

Chemistry, Medicine

Journal of pharmaceutical sciences

Obesity is a disease characterized as a condition resulting from the excess accumulation of body fat. In conjunction with increased stores of body fat, obesity has also been associated with increased mortality influenced by increased incidence of hypertension, atherosclerosis and coronary artery disease, diabetes, cancers of the breast, colon, prostate, endometrium, ovary, and cervix, and decreased overall survivability when compared with nonobese counterparts.1-5 As a consequence, obese… CONTINUE READING

View on PubMed

faculty.ksu.edu.sa

Save to Library

Create Alert

Cite

Launch Research Feed